MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Botulinum toxin: Clinical applications: dystonia"

  • 2024 International Congress

    Demographics of Botulinum toxin therapy population representative to demographics in Essex County, USA

    B. Puccio, Y. Xu, J. Acquaviva, E. Feinstein (Newark, USA)

    Objective: To describe and compare the demographics of patients receiving botulinum toxin therapy in a single movement disorder clinic to the broader surrounding community. Background:…
  • 2024 International Congress

    Tardive Dystonia Following Risperidone Treatment : A Case Report and Therapeutic Approach

    M. Hildaria, D. Tunjungsari, A. Tiksnadi (Central Jakarta, Indonesia)

    Objective: To report a case of tardive dystonia induced by risperidone and discuss the therapeutic approach, including the use of botulinum toxin. Background: Risperidone, a…
  • 2023 International Congress

    Putting the patient’s voice at the venter: Tracking the impact of botulinum neurotoxin therapy for movement disorders using patient-reported outcomes

    S. Samadzadeh, V. Koska, J. Waskönig, PJ. Jouvenal, SGM. Meuth, HH. Hefter, PA. Albrecht (Düsseldorf, Germany)

    Objective: To investigate how patient reported outcomes (PROs) perform to document the effects of a botulinum neurotoxin (BONT) treatment of movement disorders in the clinical…
  • 2023 International Congress

    Dystonia Treatment With Injections Supplemented by TMS: the D-TWIST Study

    J. Frey, J. Yu, J. Lobo Lopes, L. Fanty, I. Malaty, A. Ramirez-Zamora, M. Wajid, J. Cagle, C. de Hemptinne, A. Wagle Shukla (Morgantown, USA)

    Objective: To evaluate the safety, feasibility, tolerability and effects of accelerated rTMS for treatment of cervical dystonia. Background: In a subgroup of patients with cervical…
  • 2023 International Congress

    Incidence of dysphagia and comorbidities in patients with cervical dystonia, analyzed by botulinum neurotoxin treatment exposure

    M. Sadeghi, A. Ukah, E. Yue, K. Becker Ifantides, N. Huang, J. Lee, R. Barbano (Irvine, USA)

    Objective: Describe real-world incidence of dysphagia and other comorbidities in adults with cervical dystonia (CD) treated and not treated with botulinum neurotoxin (BoNT). Background: Dysphagia…
  • 2023 International Congress

    Topical Botulinum-Toxin-like Alternatives: A Systematic Literature Review

    S. Maytharakcheep, O. Phokaewvarangkul, R. Bhidayasiri (bangkok, Thailand)

    Objective: To perform a systematic review exploring the relevant literature on BoNT and BoNT-like substances in topical form and clinical trials focusing on facial muscle…
  • 2023 International Congress

    blepharoplasty yes or not? a single-centre study on the influence of blepharoplasty on the treatment with botulinum toxin injections.

    A. Trinchillo, N. Cuomo, F. Iorillo, G. de Joanna, F. Habetswallner, M. Esposito (Giugliano in Campania, Italy)

    Objective: To compare the responses to the BoNT injections of patients who underwent or not to blepharoplasty (Blepharoplasty YES/NO), in order to clarify if the…
  • 2023 International Congress

    Clinical presentation and evolution of isolated focal and segmental dystonia in adults – 20 years experience from a botulinum toxin clinic

    A. Vijayaraghavan, D. Divya, S. Krishnan (Trivandrum, India)

    Objective: To provide unique data on the common patterns of muscles selected for injection and the time course of benefit and weakness for BoNT injections…
  • 2023 International Congress

    Real-world retrospective safety analysis of onabotulinumtoxinA for the treatment of patients with concurrent cervical dystonia and chronic migraine

    C. Rhyne, K. Martinez, J. Stoilova, A. Patel, K. Becker Ifantides, R. Singh, I. Yushmanova, M. Sadeghi, S. Battucci, G. Forde (Chicago, USA)

    Objective: To assess the real-world safety of onabotulinumtoxinA (onabotA) for the concomitant treatment of cervical dystonia (CD) and chronic migraine (CM). Background: In the United…
  • 2023 International Congress

    Pain and quality of life in cervical dystonia

    L. Herrmann, L. Vorbeck, A. Palisi, A. Maurer, S. Lezius, J. Mallwitz, M. Gelderblom, S. Zittel (Hamburg, Germany)

    Objective: To evaluate different aspects of quality of life (QoL) and pain prevalence, characteristics and influencing factors in patients with cervical dystonia (CD) before and…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 19
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley